Polyclonal Antibody to Transforming Growth Factor Beta 1 (TGFb1)

Host

Rabbit

Clone Number

Ig Isotype

Organism species

Homo sapiens (Human)

Concentration

500µg/mL

Application

WB; IHC; ICC; IP.

Alternative Names

TGF-B1; CED; DPD1; LAP; Camurati-Engelmann Disease; Latency-associated peptide

Item Names

Transforming Growth Factor Beta 1

Research Area

Cytokine;Tumor immunity;Infection immunity;

Citation

Uighur medicine abnormal savda munzip (ASMq) suppresses expression of collagen and TGF-β1 with concomitant induce Smad7 in human hypertrophic scar …;Low Degree Hyaluronic Acid Crosslinking Inducing the Release of TGF-Β1 in Conditioned Medium of Wharton's Jelly-Derived Stem Cells;

Buffer Formulation

0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.

Immunogen

RPA124Hu01-Recombinant Transforming Growth Factor Beta 1 (TGFb1)

Usage

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

Traits

Liquid

Purification

Antigen-specific affinity chromatography followed by Protein A affinity chromatography